These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18194133)

  • 1. Alteration of direct and indirect effects of cytomegalovirus.
    Kamar N; Mengelle C; Rostaing L
    Exp Clin Transplant; 2007 Dec; 5(2):727-30. PubMed ID: 18194133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect effects of CMV in the solid organ transplant patient.
    Paya CV
    Transpl Infect Dis; 1999; 1 Suppl 1():8-12. PubMed ID: 11565588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for cytomegalovirus prophylaxis in solid organ transplantation.
    Snydman DR
    Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.
    Griffiths P; Whitley R; Snydman DR; Singh N; Boeckh M;
    Herpes; 2008 Oct; 15(1):4-12. PubMed ID: 18983762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C; Pascual M
    Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Pescovitz MD
    Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indirect effects of cytomegalovirus infection].
    Castón Osorio JJ; Zurbano Goñi F
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():6-10. PubMed ID: 22541915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'.
    Rubin RH
    Curr Opin Infect Dis; 2007 Aug; 20(4):399-407. PubMed ID: 17609600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA
    Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus and polyomavirus BK posttransplant.
    Egli A; Binggeli S; Bodaghi S; Dumoulin A; Funk GA; Khanna N; Leuenberger D; Gosert R; Hirsch HH
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii72-viii82. PubMed ID: 17890268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of CMV in the transplant population.
    Rubin RH
    Transpl Infect Dis; 1999; 1 Suppl 1():3-7. PubMed ID: 11565584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus-associated allograft rejection in heart transplant patients.
    Potena L; Valantine HA
    Curr Opin Infect Dis; 2007 Aug; 20(4):425-31. PubMed ID: 17609604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus pneumonia in transplant recipients.
    Ison MG; Fishman JA
    Clin Chest Med; 2005 Dec; 26(4):691-705, viii. PubMed ID: 16263406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant.
    Florescu DF; Qiu F; Schmidt CM; Kalil AC
    Clin Infect Dis; 2014 Mar; 58(6):785-803. PubMed ID: 24385444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed occurrence of cytomegalovirus disease in organ transplant recipients receiving antiviral prophylaxis: are we winning the battle only to lose the war?
    Singh N
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):643-6. PubMed ID: 12373496
    [No Abstract]   [Full Text] [Related]  

  • 17. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral infection in the renal transplant recipient.
    Kotton CN; Fishman JA
    J Am Soc Nephrol; 2005 Jun; 16(6):1758-74. PubMed ID: 15829710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect effects of cytomegalovirus: can we prevent them?
    Razonable R
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):1-5. PubMed ID: 20022410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.